BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8534419)

  • 21. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
    Shen ZX
    Med Hypotheses; 2004; 63(2):298-307. PubMed ID: 15236794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinesterases in the amyloid angiopathy of Alzheimer's disease.
    Mesulam M; Carson K; Price B; Geula C
    Ann Neurol; 1992 May; 31(5):565-9. PubMed ID: 1375822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
    Lane RM; Potkin SG; Enz A
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
    Kalaria RN; Kroon SN; Grahovac I; Perry G
    Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholinesterase protein level is preserved in the Alzheimer's brain.
    Campanari ML; García-Ayllón MS; Blazquez-Llorca L; Luk WK; Tsim K; Sáez-Valero J
    J Mol Neurosci; 2014 Jul; 53(3):446-53. PubMed ID: 24318838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Marquis JK; Volicer L; Mark KA; Direnfeld LK; Freedman M
    Biol Psychiatry; 1985 Jun; 20(6):605-10. PubMed ID: 3995108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
    Arendt T; Brückner MK; Lange M; Bigl V
    Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?
    Giacobini E
    Drugs Aging; 2001; 18(12):891-8. PubMed ID: 11888344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM; Geula C; Morán MA
    Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease.
    Small DH; Michaelson S; Sberna G
    Neurochem Int; 1996; 28(5-6):453-83. PubMed ID: 8792327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer's disease.
    Darvesh S; Banfield S; Dufour M; Forrestall KL; Maillet H; Reid GA; Sands D; Pottie IR
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2225797. PubMed ID: 38061987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease.
    Shen ZX
    Med Hypotheses; 2004; 63(2):308-21. PubMed ID: 15236795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholinesterase provides deeper insights into Alzheimer's disease.
    Shen ZX
    Med Hypotheses; 1994 Jul; 43(1):21-30. PubMed ID: 7968717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides.
    Alvarez A; Bronfman F; Pérez CA; Vicente M; Garrido J; Inestrosa NC
    Neurosci Lett; 1995 Dec; 201(1):49-52. PubMed ID: 8830310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinesterase inhibitors: new roles and therapeutic alternatives.
    Giacobini E
    Pharmacol Res; 2004 Oct; 50(4):433-40. PubMed ID: 15304240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterases: roles in the brain during health and disease.
    Ballard CG; Greig NH; Guillozet-Bongaarts AL; Enz A; Darvesh S
    Curr Alzheimer Res; 2005 Jul; 2(3):307-18. PubMed ID: 15974896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.
    Morán MA; Mufson EJ; Gómez-Ramos P
    Acta Neuropathol; 1993; 85(4):362-9. PubMed ID: 8480510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholinesterase and its inhibition in Alzheimer disease.
    Lane RM; Kivipelto M; Greig NH
    Clin Neuropharmacol; 2004; 27(3):141-9. PubMed ID: 15190239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.